Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,138
Closed -$256K 793
2023
Q1
$256K Sell
10,138
-7,641
-43% -$190K ﹤0.01% 652
2022
Q4
$405K Buy
17,779
+114
+0.6% +$3.02K 0.01% 501
2022
Q3
$447K Sell
17,665
-200
-1% -$5.88K 0.01% 431
2022
Q2
$543K Buy
17,865
+685
+4% +$24.3K 0.01% 370
2022
Q1
$604K Sell
17,180
-38
-0.2% -$1.35K 0.01% 364
2021
Q4
$615K Buy
17,218
+190
+1% +$6.4K 0.01% 356
2021
Q3
$555K Buy
17,028
+2,246
+15% +$60.9K 0.01% 360
2021
Q2
$388K Buy
14,782
+1,079
+8% +$28.7K ﹤0.01% 479
2021
Q1
$358K Buy
13,703
+1,574
+13% +$44K ﹤0.01% 482
2020
Q4
$339K Sell
12,129
-3,624
-23% -$101K ﹤0.01% 424
2020
Q3
$426K Buy
15,753
+3,682
+31% +$102K 0.01% 326
2020
Q2
$295K Buy
+12,071
New +$287K 0.01% 402
2020
Q1
Sell
-14,041
Closed -$281K 567
2019
Q4
$281K Sell
14,041
-1,488
-10% -$31.2K ﹤0.01% 427
2019
Q3
$342K Buy
15,529
+6,127
+65% +$137K 0.01% 372
2019
Q2
$233K Sell
9,402
-893
-9% -$21.2K ﹤0.01% 469
2019
Q1
$223K Buy
+10,295
New +$231K ﹤0.01% 467
2018
Q2
Sell
-10,381
Closed -$295K 562
2018
Q1
$295K Hold
10,381
0.01% 342
2017
Q4
$312K Buy
10,381
+2,830
+37% +$89.2K 0.01% 326
2017
Q3
$241K Buy
+7,551
New +$251K 0.01% 359

Other funds holding PHI

Greenleaf Trust's PHI Position: Q2 2023 in Review

Greenleaf Trust sold out of PLDT (PHI) in Q2 2023, closing a stake of 10,138 shares — an estimated $256K sold.

Greenleaf Trust first reported a position in PHI in Q3 2017 and held it in 19 quarters. The position peaked at $615K in Q4 2021. 63 funds tracked by Wall St. Rank hold PHI as of Q2 2023.

  • Greenleaf Trust reported no remaining PLDT position as of Q2 2023 after selling out during the quarter.
  • Greenleaf Trust sold 10,138 PLDT shares in Q2 2023, an estimated $256K.
  • Greenleaf Trust first reported a position in PLDT in Q3 2017 and held it in 19 quarters.
  • Greenleaf Trust's PLDT position peaked at $615K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held PLDT as of Q2 2023.

Based on Greenleaf Trust's 13F filing for Q2 2023, filed 9 Aug 2023.